BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32991684)

  • 1. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
    McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
    Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma.
    McDonald WC; Banerji N; McDonald KN; Ho B; Macias V; Kajdacsy-Balla A
    Arch Pathol Lab Med; 2017 Jan; 141(1):104-112. PubMed ID: 27227698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
    Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
    Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
    Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
    Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
    BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
    Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the identities of null cell tumours: Epigenomics corroborate subtle histological cues in pituitary neuroendocrine tumour/adenoma classification.
    Dottermusch M; Schüller U; Hagel C; Saeger W
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12870. PubMed ID: 36527335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas.
    Sano T; Mader R; Asa SL; Qian ZR; Hino A; Yamada S
    Endocr Pathol; 2003; 14(4):363-8. PubMed ID: 14739492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex immunoassays of peptide hormones extracted from formalin-fixed, paraffin-embedded tissue accurately subclassify pituitary adenomas.
    Strathmann FG; Borlee G; Born DE; Gonzalez-Cuyar LF; Huber BR; Baird GS
    Clin Chem; 2012 Feb; 58(2):366-74. PubMed ID: 22205691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.
    Kobayashi I; Oka H; Naritaka H; Sato Y; Fujii K; Kameya T
    Endocr Pathol; 2002; 13(2):83-98. PubMed ID: 12165656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No mutations in TPIT, a corticotroph-specific gene, in human tumoral pituitary ACTH-secreting cells.
    Bucciarelli LG; Pecori Giraldi F; Cavagnini F
    J Endocrinol Invest; 2005 Dec; 28(11):1015-8. PubMed ID: 16483181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.
    Jastania RA; Alsaad KO; Al-Shraim M; Kovacs K; Asa SL
    Endocr Pathol; 2005; 16(3):187-94. PubMed ID: 16299401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.
    Cooper O; Ben-Shlomo A; Bonert V; Bannykh S; Mirocha J; Melmed S
    Horm Cancer; 2010 Apr; 1(2):80-92. PubMed ID: 20717480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological features of pituitary adenomas and sellar region masses.
    Kleinschmidt-DeMasters BK
    Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):476-484. PubMed ID: 27763894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Pathological Aspects of Silent Pituitary Adenomas.
    Drummond J; Roncaroli F; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2473-2489. PubMed ID: 30020466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.